Microneedling with GHK-Cu peptide for hair regrowth: A clinical review
Saxenda is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities, and in adolescents aged 12 years and above with obesity
Studies show 39-40 percent of weight lost on semaglutide comes from lean mass rather than fat
As more patients explore growth hormone secretagogues for recovery, body composition, and longevity support, choosing the right delivery method has become an important part of treatment planning
Our licensed nurse providers conduct a thorough intake covering your health history, current medications, prior weight loss attempts, and goals before any clinical recommendation is made
Our guide on microdosing GLP-1 for autoimmune conditions explores gentler approaches for this population